Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heron Therapeutics

2.02
-0.0200-0.98%
Post-market: 2.020.00000.00%16:04 EDT
Volume:1.05M
Turnover:2.12M
Market Cap:308.18M
PE:-36.00
High:2.09
Open:2.06
Low:1.99
Close:2.04
Loading ...

Heron Therapeutics Holds Annual Stockholders Meeting

TIPRANKS
·
18 Jun

Heron Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
18 Jun

HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target

MT Newswires Live
·
09 Jun

Heron Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
09 Jun

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires Live
·
07 May

Heron Settles Patent Litigation With Mylan Over Cinvanti, Aponvie; Shares Rise

MT Newswires Live
·
06 May

Heron Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Heron Therapeutics Q1 EPS $0.01 Beats $(0.01) Estimate, Sales $38.90M Beat $37.42M Estimate

Benzinga
·
06 May

Heron Therapeutics Settles Patent Dispute with Mylan

TIPRANKS
·
06 May

Heron Therapeutics Q1 EPS USD 0.01

THOMSON REUTERS
·
06 May

Heron Therapeutics: Adjusted Ebitda Guidance Raised to a Range of $4 Mln - $12 Mln for FY 2025

THOMSON REUTERS
·
06 May

BRIEF-Heron Therapeutics Announces Settlement With Mylan Related To Cinvanti® And Aponvie® Patent Litigations

Reuters
·
06 May

Heron Therapeutics: Grants Mylan License to Market Generic Cinvanti and Aponvie Beginning June 2032

THOMSON REUTERS
·
06 May

Heron Therapeutics Announces Settlement With Mylan Related to Cinvanti® and Aponvie® Patent Litigations

THOMSON REUTERS
·
06 May

Heron Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
02 May

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks
·
29 Apr

Heron Therapeutics Appoints Mark Hensley as COO

TIPRANKS
·
29 Apr

Heron Therapeutics Names Mark Hensley as COO

MT Newswires Live
·
29 Apr

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

THOMSON REUTERS
·
29 Apr

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

PR Newswire
·
29 Apr